Eurordis-Rare Diseases Europe

Eurordis-Rare Diseases Europe company information, Employees & Contact Information

EURORDIS-Rare Diseases Europe is a unique, non-profit alliance of over 1,000 rare disease patient organisations from more than 70 countries that work together to improve the lives of all people living with rare diseases in Europe. By connecting and mobilising all stakeholders from within and outside the rare disease community, EURORDIS strengthens the voice of people living with rare diseases and shapes research, policies and services. Our vision is a world where all people living with a rare disease can have longer and better lives and can achieve their full potential, in a society that values their well-being and leaves no-one behind. To achieve their full potential, people living with a rare disease need to be: - recognised as equal citizens with their rights fully respected - diagnosed timely and accurately - supported by state-of-the-art medical and social care, or cured - included in society in all aspects of life and enabled to live independently Our mission is to work across borders and diseases to improve the lives of all people living with rare diseases.
Looking for a particular Eurordis-Rare Diseases Europe employee's phone or email?

Eurordis-Rare Diseases Europe Questions

News

Integrative research and innovation strategy for rare diseases. Insights from the 5-year European joint programme on rare diseases, including analysis to inform recommendations for future actions - Health Research Policy and Systems

Integrative research and innovation strategy for rare diseases. Insights from the 5-year European joint programme on rare diseases, including analysis to inform recommendations for future actions Health Research Policy and Systems

Pharma Industry News and Analysis - FirstWord Pharma

Pharma Industry News and Analysis FirstWord Pharma

Rare Diseases in Egypt: A New Era of Transformation - Dailynewsegypt

Rare Diseases in Egypt: A New Era of Transformation Dailynewsegypt

Time to diagnosis and determinants of diagnostic delays of people living with a rare disease: results of a Rare Barometer retrospective patient survey | European Journal of Human Genetics - Nature

Time to diagnosis and determinants of diagnostic delays of people living with a rare disease: results of a Rare Barometer retrospective patient survey | European Journal of Human Genetics Nature

CZI Awards $1.3 Million to Support the Global Rare Disease Community - Chan Zuckerberg Initiative

CZI Awards $1.3 Million to Support the Global Rare Disease Community Chan Zuckerberg Initiative

Lack of Information on the Effects of COVID-19 on Rare Pathologies Has Further Hampered Access to Healthcare Services - Frontiers

Lack of Information on the Effects of COVID-19 on Rare Pathologies Has Further Hampered Access to Healthcare Services Frontiers

EURORDIS Award Contest Welcomes Photos of Life With Rare Disease - Adrenoleukodystrophy News

EURORDIS Award Contest Welcomes Photos of Life With Rare Disease Adrenoleukodystrophy News

Urgent Support and Aid Needed for Ukrainian Patients with Rare Diseases and their Families - European Medical Journal

Urgent Support and Aid Needed for Ukrainian Patients with Rare Diseases and their Families European Medical Journal

Market Access Programs for Rare-Disease Treatments - BioProcess International

Market Access Programs for Rare-Disease Treatments BioProcess International

Takeda’s focus on health equity: Rare Disease Day 2023 | Takeda Stories - Takeda Pharmaceuticals

Takeda’s focus on health equity: Rare Disease Day 2023 | Takeda Stories Takeda Pharmaceuticals

Quantifying hope: an EU perspective of rare disease therapeutic space and market dynamics - Frontiers

Quantifying hope: an EU perspective of rare disease therapeutic space and market dynamics Frontiers

Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database - Nature

Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database Nature

Recommendations from the IRDiRC Working Group on methodologies to assess the impact of diagnoses and therapies on rare disease patients - Orphanet Journal of Rare Diseases

Recommendations from the IRDiRC Working Group on methodologies to assess the impact of diagnoses and therapies on rare disease patients Orphanet Journal of Rare Diseases

Valuing the “Burden” and Impact of Rare Diseases: A Scoping Review - Frontiers

Valuing the “Burden” and Impact of Rare Diseases: A Scoping Review Frontiers

Coding undiagnosed rare disease patients in health information systems: recommendations from the RD-CODE project - Orphanet Journal of Rare Diseases

Coding undiagnosed rare disease patients in health information systems: recommendations from the RD-CODE project Orphanet Journal of Rare Diseases

Rare disease emerging as a global public health priority - Frontiers

Rare disease emerging as a global public health priority Frontiers

The road to successful people-centric research in rare diseases: the web-based case study of the Immunology and Congenital Disorders of Glycosylation questionnaire (ImmunoCDGQ) - Orphanet Journal of Rare Diseases

The road to successful people-centric research in rare diseases: the web-based case study of the Immunology and Congenital Disorders of Glycosylation questionnaire (ImmunoCDGQ) Orphanet Journal of Rare Diseases

An Objective Approach to Identify Priority Rare Diseases for the Development of Solutions Reducing the Diagnostic Delay Based on French Data - Frontiers

An Objective Approach to Identify Priority Rare Diseases for the Development of Solutions Reducing the Diagnostic Delay Based on French Data Frontiers

Obstacles and expectations of rare disease patients and their families in Türkiye: ISTisNA project survey results - Frontiers

Obstacles and expectations of rare disease patients and their families in Türkiye: ISTisNA project survey results Frontiers

Editorial: Vaccination in children with immune-mediated diseases - Frontiers

Editorial: Vaccination in children with immune-mediated diseases Frontiers

Meeting abstracts from the 12th European Conference on Rare Diseases and Orphan Products - Orphanet Journal of Rare Diseases

Meeting abstracts from the 12th European Conference on Rare Diseases and Orphan Products Orphanet Journal of Rare Diseases

Availability and Accessibility of Orphan Medicinal Products to Patients in Slovakia in the Years 2010–2019 - Frontiers

Availability and Accessibility of Orphan Medicinal Products to Patients in Slovakia in the Years 2010–2019 Frontiers

Rare diseases in Chile: challenges and recommendations in universal health coverage context - Orphanet Journal of Rare Diseases

Rare diseases in Chile: challenges and recommendations in universal health coverage context Orphanet Journal of Rare Diseases

Colpitts Clinical Staff Show Dedication to Research at Boston’s Rare Disease Day - Massachusetts Biotechnology Council

Colpitts Clinical Staff Show Dedication to Research at Boston’s Rare Disease Day Massachusetts Biotechnology Council

Sean Hepburn Ferrer Partners with NORD and EURORDIS to Help People Living with Rare Diseases - PR Newswire

Sean Hepburn Ferrer Partners with NORD and EURORDIS to Help People Living with Rare Diseases PR Newswire

Research priorities for rare neurological diseases: a representative view of patient representatives and healthcare professionals from the European Reference Network for Rare Neurological Diseases - Orphanet Journal of Rare Diseases

Research priorities for rare neurological diseases: a representative view of patient representatives and healthcare professionals from the European Reference Network for Rare Neurological Diseases Orphanet Journal of Rare Diseases

Drug repurposing for rare: progress and opportunities for the rare disease community - Frontiers

Drug repurposing for rare: progress and opportunities for the rare disease community Frontiers

Orphan drugs’ clinical uncertainty and prices: Addressing allocative and technical inefficiencies in orphan drug reimbursement - Frontiers

Orphan drugs’ clinical uncertainty and prices: Addressing allocative and technical inefficiencies in orphan drug reimbursement Frontiers

Treat Iron-Related Childhood-Onset Neurodegeneration (TIRCON)—An International Network on Care and Research for Patients With Neurodegeneration With Brain Iron Accumulation (NBIA) - Frontiers

Treat Iron-Related Childhood-Onset Neurodegeneration (TIRCON)—An International Network on Care and Research for Patients With Neurodegeneration With Brain Iron Accumulation (NBIA) Frontiers

The economic burden of diagnostic uncertainty on rare disease patients - BMC Health Services Research

The economic burden of diagnostic uncertainty on rare disease patients BMC Health Services Research

Rare disease clinical trials - PharmaTimes

Rare disease clinical trials PharmaTimes

Prioritization of research engaged with rare disease stakeholders: a systematic review and thematic analysis - Orphanet Journal of Rare Diseases

Prioritization of research engaged with rare disease stakeholders: a systematic review and thematic analysis Orphanet Journal of Rare Diseases

The EuroBioBank Network: 10 years of hands-on experience of collaborative, transnational biobanking for rare diseases - Nature

The EuroBioBank Network: 10 years of hands-on experience of collaborative, transnational biobanking for rare diseases Nature

Genetic Testing for Rare Diseases: A Systematic Review of Ethical Aspects - Frontiers

Genetic Testing for Rare Diseases: A Systematic Review of Ethical Aspects Frontiers

Nationwide comprehensive epidemiological study of rare diseases in Japan using a health insurance claims database - Orphanet Journal of Rare Diseases

Nationwide comprehensive epidemiological study of rare diseases in Japan using a health insurance claims database Orphanet Journal of Rare Diseases

Drug repurposing in Rett and Rett-like syndromes: a promising yet underrated opportunity? - Frontiers

Drug repurposing in Rett and Rett-like syndromes: a promising yet underrated opportunity? Frontiers

Innovation in Informatics to Improve Clinical Care and Drug Accessibility for Rare Diseases in China - Frontiers

Innovation in Informatics to Improve Clinical Care and Drug Accessibility for Rare Diseases in China Frontiers

A Review of Rare Disease Policies and Orphan Drug Reimbursement Systems in 12 Eurasian Countries - Frontiers

A Review of Rare Disease Policies and Orphan Drug Reimbursement Systems in 12 Eurasian Countries Frontiers

The importance of international collaboration for rare diseases research: a European perspective - Nature

The importance of international collaboration for rare diseases research: a European perspective Nature

Mental health care for rare disease in the UK – recommendations from a quantitative survey and multi-stakeholder workshop - BMC Health Services Research

Mental health care for rare disease in the UK – recommendations from a quantitative survey and multi-stakeholder workshop BMC Health Services Research

The patient pathway in ATTR-CM in Greece and how to improve it: A multidisciplinary perspective - ScienceDirect.com

The patient pathway in ATTR-CM in Greece and how to improve it: A multidisciplinary perspective ScienceDirect.com

The Italian neuromuscular registry: a coordinated platform where patient organizations and clinicians collaborate for data collection and multiple usage - Orphanet Journal of Rare Diseases

The Italian neuromuscular registry: a coordinated platform where patient organizations and clinicians collaborate for data collection and multiple usage Orphanet Journal of Rare Diseases

Comparing access to orphan medicinal products in Europe - Orphanet Journal of Rare Diseases

Comparing access to orphan medicinal products in Europe Orphanet Journal of Rare Diseases

Patient access to orphan drugs in France - Orphanet Journal of Rare Diseases

Patient access to orphan drugs in France Orphanet Journal of Rare Diseases

Improving the informed consent process in international collaborative rare disease research: effective consent for effective research - Nature

Improving the informed consent process in international collaborative rare disease research: effective consent for effective research Nature

For patients with rare diseases, European public health policies must work harder - The Parliament Magazine

For patients with rare diseases, European public health policies must work harder The Parliament Magazine

A diagnostic support system based on pain drawings: binary and k-disease classification of EDS, GBS, FSHD, PROMM, and a control group with Pain2D - Orphanet Journal of Rare Diseases

A diagnostic support system based on pain drawings: binary and k-disease classification of EDS, GBS, FSHD, PROMM, and a control group with Pain2D Orphanet Journal of Rare Diseases

Awardee of the Black Pearl Member Award 2024: Dr Ritu Jain | School of Humanities | NTU Singapore - Nanyang Technological University - NTU Singapore

Awardee of the Black Pearl Member Award 2024: Dr Ritu Jain | School of Humanities | NTU Singapore Nanyang Technological University - NTU Singapore

Top Eurordis-Rare Diseases Europe Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant